Major drugmakers turn to China for licensing deals

Factbox lists recent licensing deals between major drugmakers and Chinese biotechs, including Novo Nordisk's pact with Jiangsu Hengrui for an experimental weight-loss pill. It also cites several deals involving Merck, Pfizer, Eli Lilly, Bristol Myers Squibb, GSK and Roche.